- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-12-20
DOI
10.3389/fimmu.2016.00606
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dysregulation of regulatory CD56 bright NK cells/T cells interactions in multiple sclerosis
- (2016) Alice Laroni et al. JOURNAL OF AUTOIMMUNITY
- Relationship ofNKG2CCopy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets
- (2016) Aura Muntasell et al. JOURNAL OF IMMUNOLOGY
- Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation
- (2016) Qiang Liu et al. NATURE NEUROSCIENCE
- Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
- (2016) Catharina C. Gross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
- (2016) Obinna Chijioke et al. Frontiers in Immunology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis
- (2015) E. Rodríguez-Martín et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
- (2015) Tobias Ruck et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade
- (2015) M. Mehling et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Cytomegalovirus: a culprit or protector in multiple sclerosis?
- (2015) Marjan Vanheusden et al. TRENDS IN MOLECULAR MEDICINE
- Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis
- (2015) Jose E Martínez-Rodríguez et al. Multiple Sclerosis Journal
- Optimizing therapy early in multiple sclerosis: An evidence-based view
- (2015) Tjalf Ziemssen et al. Multiple Sclerosis and Related Disorders
- Role for early-differentiated natural killer cells in infectious mononucleosis
- (2014) T. Azzi et al. BLOOD
- Regulatory T cells in autoimmune neuroinflammation
- (2014) Markus Kleinewietfeld et al. IMMUNOLOGICAL REVIEWS
- Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases
- (2014) S. Han et al. JOURNAL OF IMMUNOLOGY
- Proliferation Conditions Promote Intrinsic Changes in NK Cells for an IL-10 Response
- (2014) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells
- (2014) Guido Ferlazzo et al. Frontiers in Immunology
- Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
- (2013) Fabio Morandi et al. Journal of Neuroimmune Pharmacology
- Epstein-Barr Virus Coinfection in Children Boosts Cytomegalovirus-Induced Differentiation of Natural Killer Cells
- (2013) S. Saghafian-Hedengren et al. JOURNAL OF VIROLOGY
- HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients
- (2013) Kim Pannemans et al. Multiple Sclerosis Journal
- Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
- (2013) Coralie Chanvillard et al. Frontiers in Immunology
- Increased HLA-E expression in white matter lesions in multiple sclerosis
- (2012) Pascal F. Durrenberger et al. IMMUNOLOGY
- Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
- (2012) Isabell Hamann et al. JOURNAL OF NEUROIMMUNOLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
- (2012) Natasja Nielsen et al. PLoS One
- Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
- (2012) Barbara Morandi et al. PLoS One
- Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
- (2012) J. S. A. Perry et al. Science Translational Medicine
- Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
- (2011) T. A. Johnson et al. JOURNAL OF IMMUNOLOGY
- Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
- (2011) W. Jiang et al. JOURNAL OF IMMUNOLOGY
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
- (2011) Mario Skarica et al. JOURNAL OF NEUROIMMUNOLOGY
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Intrathecal effects of daclizumab treatment of multiple sclerosis
- (2011) B. Bielekova et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
- (2011) Alice Laroni et al. PLoS One
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph
- (2010) Erika Montalto et al. IMMUNOLOGY LETTERS
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology
- (2010) Junwei Hao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
- (2010) J. F. Martin et al. JOURNAL OF IMMUNOLOGY
- Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2
- (2010) J. W. Leavenworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- (2009) Bibiana Bielekova et al. ARCHIVES OF NEUROLOGY
- Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
- (2009) E. Marcenaro et al. BLOOD
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
- (2009) Glinda S. Cooper et al. JOURNAL OF AUTOIMMUNITY
- T-bet–dependent S1P5expression in NK cells promotes egress from lymph nodes and bone marrow
- (2009) Craig N. Jenne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection
- (2009) Seung-Hwan Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of the innate immune system in the pathogenesis of multiple sclerosis
- (2009) Roopali Gandhi et al. JOURNAL OF NEUROIMMUNOLOGY
- Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
- (2008) Philip L. De Jager et al. BRAIN
- Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
- (2008) J. D. Lunemann et al. BRAIN
- CD56brightnatural killer (NK) cells: an important NK cell subset
- (2008) Aurélie Poli et al. IMMUNOLOGY
- Role of natural killer cells in the pathogenesis and progression of multiple sclerosis
- (2007) Barbara Morandi et al. PHARMACOLOGICAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started